Related Experiment Video

Updated: Aug 17, 2026

Isolation of Pulmonary Artery Smooth Muscle Cells from Neonatal Mice
08:02

Isolation of Pulmonary Artery Smooth Muscle Cells from Neonatal Mice

Published on: October 19, 2013

Smooth muscle cell hypertrophy versus hyperplasia in infantile hypertrophic pyloric stenosis

T Oue1, P Puri

  • 1Children's Research Centre, Our Lady's Hospital for Sick Children, Crumlin, Dublin, Ireland.

Pediatric Research
|June 15, 1999
PubMed

Insights

Infantile hypertrophic pyloric stenosis (IHPS) involves increased pyloric smooth muscle. This study found both increased cell size (hypertrophy) and number (hyperplasia) contribute to muscle enlargement in IHPS patients.

Area of Science:

  • Pediatric Surgery
  • Developmental Biology
  • Gastroenterology

Background:

  • Infantile hypertrophic pyloric stenosis (IHPS) is a common congenital anomaly.
  • The exact cellular mechanism behind pyloric muscle enlargement in IHPS remains unclear.
  • Understanding whether cell size (hypertrophy) or cell number (hyperplasia) drives this enlargement is crucial.

Purpose of the Study:

  • To investigate the cellular mechanisms of pyloric muscle enlargement in IHPS.
  • To compare the proliferative activity, cell size, and cell number of smooth muscle in IHPS patients versus controls.
  • To elucidate the roles of hypertrophy and hyperplasia in IHPS.

Main Methods:

  • Muscle biopsy specimens were collected from 18 IHPS patients and 11 age-matched controls.
  • Immunohistochemistry using MAb MIB-1 was performed to assess cellular proliferation (proliferative index, PI).
  • Image analysis was used to quantify smooth muscle cell number per bundle and cell size.

Main Results:

  • The proliferative index (PI) was significantly higher in IHPS patients (9.6%) compared to controls (1.3%).
  • A significant inverse correlation was observed between PI and age at operation.
  • Both smooth muscle cell number per bundle and cell size were significantly greater in IHPS patients than in controls.

Conclusions:

  • Pyloric muscle enlargement in IHPS is a result of both increased smooth muscle cell number (hyperplasia) and increased cell size (hypertrophy).
  • The findings highlight the complex cellular processes underlying IHPS.
  • Further research into the regulation of smooth muscle proliferation and growth in IHPS is warranted.

More Related Videos

Using In Vivo and Tissue and Cell Explant Approaches to Study the Morphogenesis and Pathogenesis of the Embryonic and Perinatal Aorta10:57

Using In Vivo and Tissue and Cell Explant Approaches to Study the Morphogenesis and Pathogenesis of the Embryonic and Perinatal Aorta

Published on: September 12, 2017

A Mouse Model of Intestinal Partial Obstruction07:33

A Mouse Model of Intestinal Partial Obstruction

Published on: March 5, 2018

Related Concept Videos

Smooth Muscle Contraction01:25

Smooth Muscle Contraction

Smooth muscle contraction is a complex process vital for various bodily functions, from maintaining blood vessel tension to facilitating the movement of food through the digestive tract. Unlike striated muscles, smooth muscle contraction begins more slowly and lasts longer.
The onset of contraction is triggered by an increase in calcium ions within the sarcoplasm, similar to the process in striated muscle. However, smooth muscles have a relatively smaller reservoir of the sarcoplasmic...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...
Cellular Adaptation III: Hyperplasia01:26

Cellular Adaptation III: Hyperplasia

Hyperplasia is an increase in the number of cells in a tissue or organ due to enhanced cell division. It is an adaptive, controlled response to stimuli such as injury, hormones, or stress, involving mitosis to produce genetically identical cells and support tissue repair and regeneration.Tissue CapacityCertain tissues, including the epidermis, intestinal epithelium, bone marrow, and fibroblasts, have a high potential for hyperplasia. Others, such as bone, cartilage, and smooth muscle, show...
Cellular Adaptation IV: Dysplasia and Metaplasia01:24

Cellular Adaptation IV: Dysplasia and Metaplasia

DysplasiaDysplasia refers to abnormal changes in the size, shape, and organization of mature cells, characterized by pleomorphism, nuclear abnormalities, and increased mitotic activity. It commonly affects epithelial tissues, including the cervix, gastrointestinal tract, respiratory mucosa, and endometrium. Although it may occur alongside hyperplasia, dysplasia is not a true adaptive response but a preneoplastic change with potential to progress to cancer.When confined above the basement...
Pyloric Obstruction01:11

Pyloric Obstruction

Pyloric obstruction, also referred to as gastric outlet obstruction, is a condition characterized by narrowing or blockage at the pylorus—the muscular valve regulating the flow of stomach contents into the duodenum. When this passage becomes impaired, the stomach cannot effectively empty its contents into the small intestine. This disruption leads to a range of gastrointestinal symptoms, including early satiety, bloating, epigastric pain, postprandial nausea, persistent vomiting, and...